| Amgen (AMGN) |
US |
$179.625B |
17.97 |
| Vertex Pharmaceuticals (VRTX) |
US |
$127.803B |
32.89 |
| Regeneron Pharmaceuticals (REGN) |
US |
$118.850B |
29.07 |
| Bristol Myers Squibb (BMY) |
US |
$102.267B |
36.82 |
| CSL (CSLLY) |
AU |
$98.149B |
0.00 |
| Gilead Sciences (GILD) |
US |
$95.943B |
19.11 |
| GSK (GSK) |
GB |
$82.611B |
9.87 |
| Moderna (MRNA) |
US |
$46.797B |
0.00 |
| Biogen (BIIB) |
US |
$30.746B |
14.08 |
| Alnylam Pharmaceuticals (ALNY) |
US |
$29.705B |
0.00 |
| Argenex SE (ARGX) |
NL |
$29.386B |
0.00 |
| BioNTech SE (BNTX) |
DE |
$20.430B |
171.88 |
| Illumina (ILMN) |
US |
$19.185B |
136.85 |
| Genmab (GMAB) |
DK |
$18.770B |
22.00 |
| BioMarin Pharmaceutical (BMRN) |
US |
$16.062B |
62.66 |
| BeiGene (BGNE) |
KY |
$15.760B |
0.00 |
| Incyte (INCY) |
US |
$15.406B |
23.82 |
| Sarepta Therapeutics (SRPT) |
US |
$13.634B |
1202.00 |
| Bio-Techne Corp (TECH) |
US |
$12.701B |
47.98 |
| Insmed (INSM) |
US |
$11.077B |
0.00 |
| Legend Biotech (LEGN) |
US |
$10.319B |
0.00 |
| QIAGEN (QGEN) |
NL |
$10.027B |
21.42 |
| Vaxcyte (PCVX) |
US |
$9.144B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
US |
$8.487B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
US |
$8.393B |
27.45 |
| Exact Sciences (EXAS) |
US |
$8.359B |
0.00 |
| Roivant Sciences (ROIV) |
GB |
$7.978B |
0.00 |
| Repligen (RGEN) |
US |
$7.867B |
102.77 |
| Ascendis Pharma (ASND) |
DK |
$7.788B |
0.00 |
| Viking Therapeutics (VKTX) |
US |
$7.310B |
0.00 |
| Halozyme Therapeutics (HALO) |
US |
$7.157B |
19.87 |
| Exelixis (EXEL) |
US |
$7.092B |
36.55 |
| Blueprint Medicines (BPMC) |
US |
$7.025B |
0.00 |
| Zealand Pharma (ZLDPF) |
DK |
$6.658B |
0.00 |
| Cytokinetics (CYTK) |
US |
$6.259B |
0.00 |
| Krystal Biotech (KRYS) |
US |
$6.102B |
0.00 |
| Nuvalent (NUVL) |
US |
$5.268B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$4.918B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
US |
$4.824B |
0.00 |
| Avidity Biosciences (RNA) |
US |
$4.604B |
0.00 |
| Alkermes (ALKS) |
IE |
$4.591B |
16.12 |
| Immunovant (IMVT) |
US |
$4.254B |
0.00 |
| Axsome Therapeutics (AXSM) |
US |
$4.110B |
0.00 |
| Guardant Health (GH) |
US |
$4.038B |
0.00 |
| ImmunityBio (IBRX) |
US |
$3.880B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
US |
$3.729B |
0.00 |
| Biohaven (BHVN) |
US |
$3.639B |
0.00 |
| Arcellx (ACLX) |
US |
$3.446B |
0.00 |
| Denali Therapeutics (DNLI) |
US |
$3.437B |
0.00 |
| Twist Bioscience (TWST) |
US |
$3.382B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
CA |
$3.318B |
0.00 |
| HUTCHMED (China) (HCM) |
HK |
$3.234B |
0.00 |
| IDEAYA Biosciences (IDYA) |
US |
$3.208B |
0.00 |
| Merus (MRUS) |
NL |
$3.180B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
US |
$3.162B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$3.051B |
119.64 |
| Amicus Therapeutics (FOLD) |
US |
$3.015B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
US |
$2.991B |
0.00 |
| Celldex Therapeutics (CLDX) |
US |
$2.937B |
0.00 |
| Apogee Therapeutics (APGE) |
US |
$2.920B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
CH |
$2.860B |
0.00 |
| Morphic Holding (MORF) |
US |
$2.833B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
US |
$2.818B |
0.00 |
| MorphoSys AG (MOR) |
DE |
$2.773B |
0.00 |
| Geron (GERN) |
US |
$2.764B |
0.00 |
| Kymera Therapeutics (KYMR) |
US |
$2.733B |
0.00 |
| Beam Therapeutics (BEAM) |
US |
$2.728B |
0.00 |
| Iovance Biotherapeutics (IOVA) |
US |
$2.588B |
0.00 |
| Intellia Therapeutics (NTLA) |
US |
$2.557B |
0.00 |
| Vericel (VCEL) |
US |
$2.543B |
0.00 |
| Certara (CERT) |
US |
$2.528B |
58.22 |
| Myriad Genetics (MYGN) |
US |
$2.503B |
0.00 |
| Fortrea Holdings (FTRE) |
US |
$2.407B |
29.58 |
| Novavax (NVAX) |
US |
$2.402B |
0.00 |
| Protagonist Therapeutics (PTGX) |
US |
$2.363B |
16.51 |
| Rocket Pharmaceuticals (RCKT) |
US |
$2.300B |
0.00 |
| Janux Therapeutics (JANX) |
US |
$2.281B |
0.00 |
| CG Oncology (CGON) |
US |
$2.204B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
US |
$2.081B |
0.00 |
| Neumora Therapeutics (NMRA) |
US |
$2.058B |
0.00 |
| Bavarian Nordic (BVNRY) |
DK |
$2.055B |
8.95 |
| NovoCure (NVCR) |
JE |
$2.047B |
0.00 |
| Mirum Pharmaceuticals (MIRM) |
US |
$2.042B |
0.00 |
| Arvinas (ARVN) |
US |
$2.029B |
0.00 |
| Vera Therapeutics (VERA) |
US |
$2.008B |
0.00 |
| Immunocore Holdings (IMCR) |
GB |
$2.007B |
0.00 |
| Akero Therapeutics (AKRO) |
US |
$1.945B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
US |
$1.929B |
31.51 |
| Harmony Biosciences Holdings (HRMY) |
US |
$1.926B |
14.68 |
| NeoGenomics (NEO) |
US |
$1.900B |
0.00 |
| Keros Therapeutics (KROS) |
US |
$1.888B |
0.00 |
| Zai Lab (ZLAB) |
CN |
$1.879B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
BM |
$1.853B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
GB |
$1.837B |
0.00 |
| Galapagos (GLPG) |
BE |
$1.811B |
0.00 |
| Structure Therapeutics (GPCR) |
US |
$1.802B |
0.00 |
| Edgewise Therapeutics (EWTX) |
US |
$1.773B |
0.00 |
| Kura Oncology (KURA) |
US |
$1.607B |
0.00 |
| MannKind (MNKD) |
US |
$1.593B |
195.00 |
| Dynavax Technologies (DVAX) |
US |
$1.520B |
193.50 |
| Belite Bio (BLTE) |
US |
$1.464B |
0.00 |
| Vir Biotechnology (VIR) |
US |
$1.456B |
0.00 |
| Longboard Pharmaceuticals (LBPH) |
US |
$1.454B |
0.00 |
| Arcus Biosciences (RCUS) |
US |
$1.438B |
0.00 |
| Sana Biotechnology (SANA) |
US |
$1.418B |
0.00 |
| Nurix Therapeutics (NRIX) |
US |
$1.413B |
0.00 |
| Day One Biopharmaceuticals (DAWN) |
US |
$1.401B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
US |
$1.327B |
16.47 |
| Prothena (PRTA) |
IE |
$1.314B |
0.00 |
| Gyre Therapeutics (GYRE) |
US |
$1.284B |
0.00 |
| Spyre Therapeutics (SYRE) |
US |
$1.268B |
0.00 |
| Autolus Therapeutics (AUTL) |
GB |
$1.242B |
0.00 |
| Arcutis Biotherapeutics (ARQT) |
US |
$1.166B |
0.00 |
| Cullinan Therapeutics (CGEM) |
US |
$1.162B |
0.00 |
| MiMedx (MDXG) |
US |
$1.145B |
48.50 |
| Disc Medicine (IRON) |
US |
$1.129B |
0.00 |
| Viridian Therapeutics (VRDN) |
US |
$1.063B |
0.00 |
| Tyra Biosciences (TYRA) |
US |
$1.056B |
0.00 |
| Bicycle Therapeutics (BCYC) |
GB |
$1.049B |
0.00 |
| Tango Therapeutics (TNGX) |
US |
$1.042B |
0.00 |
| Immatics (IMTX) |
DE |
$1.041B |
0.00 |
| AnaptysBio (ANAB) |
US |
$1.012B |
0.00 |
| Immunome (IMNM) |
US |
$0.990B |
0.00 |
| Praxis Precision Medicines (PRAX) |
US |
$0.987B |
0.00 |
| AbCellera Biologics (ABCL) |
CA |
$0.959B |
0.00 |
| Humacyte (HUMA) |
US |
$0.946B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
US |
$0.945B |
0.00 |
| Nuvation Bio (NUVB) |
US |
$0.924B |
0.00 |
| Cogent Biosciences (COGT) |
US |
$0.910B |
0.00 |
| 89BIO (ETNB) |
US |
$0.909B |
0.00 |
| Liquidia Technologies (LQDA) |
US |
$0.889B |
0.00 |
| Cytek Biosciences (CTKB) |
US |
$0.883B |
0.00 |
| Olema Pharmaceuticals (OLMA) |
US |
$0.863B |
0.00 |
| Dianthus Therapeutics (DNTH) |
US |
$0.850B |
0.00 |
| Mesoblast (MESO) |
AU |
$0.845B |
0.00 |
| CureVac (CVAC) |
DE |
$0.833B |
0.00 |
| Stoke Therapeutics (STOK) |
US |
$0.827B |
0.00 |
| CARGO Therapeutics (CRGX) |
US |
$0.819B |
0.00 |
| Ginkgo Bioworks Holdings (DNA) |
US |
$0.819B |
0.00 |
| Rapport Therapeutics (RAPP) |
|
$0.815B |
0.00 |
| Pliant Therapeutics (PLRX) |
US |
$0.807B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
US |
$0.802B |
0.00 |
| WAVE Life Sciences (WVE) |
SG |
$0.800B |
0.00 |
| Tectonic Therapeutic (TECX) |
US |
$0.792B |
0.00 |
| Zymeworks (ZYME) |
US |
$0.760B |
0.00 |
| Travere Therapeutics (TVTX) |
US |
$0.753B |
0.00 |
| ArriVent BioPharma (AVBP) |
US |
$0.750B |
0.00 |
| Abivax SA (ABVX) |
FR |
$0.746B |
0.00 |
| Scholar Rock Holding (SRRK) |
US |
$0.740B |
0.00 |
| Arbutus Biopharma (ABUS) |
US |
$0.736B |
0.00 |
| Emergent Biosolutions (EBS) |
US |
$0.732B |
0.00 |
| Replimune (REPL) |
US |
$0.707B |
0.00 |
| REGENXBIO (RGNX) |
US |
$0.706B |
0.00 |
| ACELYRIN, INC (SLRN) |
US |
$0.693B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
US |
$0.687B |
0.00 |
| Mind Medicine (MindMed) (MNMD) |
US |
$0.675B |
0.00 |
| Prime Medicine (PRME) |
US |
$0.673B |
0.00 |
| Mineralys Therapeutics (MLYS) |
US |
$0.668B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
US |
$0.665B |
0.00 |
| IGM Biosciences (IGMS) |
US |
$0.660B |
0.00 |
| Celcuity (CELC) |
US |
$0.657B |
0.00 |
| Astria Therapeutics (ATXS) |
US |
$0.655B |
0.00 |
| Avid Bioservices (CDMO) |
US |
$0.650B |
0.00 |
| GH Research (GHRS) |
IE |
$0.650B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
US |
$0.648B |
0.00 |
| Sinovac Biotech (SVA) |
CN |
$0.645B |
0.00 |
| Allogene Therapeutics (ALLO) |
US |
$0.627B |
0.00 |
| Alector (ALEC) |
US |
$0.626B |
0.00 |
| ITeos Therapeutics (ITOS) |
US |
$0.622B |
0.00 |
| Fate Therapeutics (FATE) |
US |
$0.619B |
0.00 |
| PepGen (PEPG) |
US |
$0.601B |
0.00 |
| Applied Therapeutics (APLT) |
US |
$0.596B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
US |
$0.589B |
0.00 |
| Alumis (ALMS) |
US |
$0.583B |
0.00 |
| MEREO BIOPHARMA (MREO) |
GB |
$0.583B |
0.00 |
| Terns Pharmaceuticals (TERN) |
US |
$0.583B |
0.00 |
| Neurogene (NGNE) |
US |
$0.582B |
0.00 |
| Castle Biosciences (CSTL) |
US |
$0.581B |
0.00 |
| Entrada Therapeutics (TRDA) |
US |
$0.581B |
27.33 |
| Annexon (ANNX) |
US |
$0.577B |
0.00 |
| Anavex Life Sciences (AVXL) |
US |
$0.570B |
0.00 |
| Erasca (ERAS) |
US |
$0.569B |
0.00 |
| Fulcrum Therapeutics (FULC) |
US |
$0.552B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
US |
$0.550B |
0.00 |
| Pharming Group (PHAR) |
NL |
$0.542B |
0.00 |
| Contineum Therapeutics (CTNM) |
US |
$0.540B |
0.00 |
| PureTech Health (PRTC) |
US |
$0.539B |
0.00 |
| Aura Biosciences (AURA) |
US |
$0.513B |
0.00 |
| Third Harmonic Bio (THRD) |
US |
$0.510B |
0.00 |
| GRAIL (GRAL) |
US |
$0.507B |
0.00 |
| Absci (ABSI) |
US |
$0.507B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
US |
$0.506B |
0.00 |
| Voyager Therapeutics (VYGR) |
US |
$0.504B |
0.00 |
| MaxCyte (MXCT) |
US |
$0.502B |
0.00 |
| Oculis Holding AG (OCS) |
CH |
$0.471B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
US |
$0.470B |
0.00 |
| Editas Medicine (EDIT) |
US |
$0.465B |
0.00 |
| C4 Therapeutics (CCCC) |
US |
$0.447B |
0.00 |
| Q32 Bio (QTTB) |
US |
$0.433B |
0.00 |
| Oxford BioMedica (OXBDF) |
GB |
$0.431B |
0.00 |
| Kyverna Therapeutics (KYTX) |
US |
$0.424B |
0.00 |
| Precigen (PGEN) |
US |
$0.424B |
0.00 |
| Ocugen (OCGN) |
US |
$0.422B |
0.00 |
| Revance Therapeutics (RVNC) |
US |
$0.409B |
0.00 |
| UniQure (QURE) |
NL |
$0.405B |
0.00 |
| EnGene Holdings (ENGN) |
US |
$0.397B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.387B |
0.00 |
| Alto Neuroscience (ANRO) |
US |
$0.386B |
0.00 |
| TScan Therapeutics (TCRX) |
US |
$0.384B |
0.00 |
| Urogen Pharma (URGN) |
US |
$0.383B |
0.00 |
| Poseida Therapeutics (PSTX) |
US |
$0.383B |
0.00 |
| Sutro Biopharma (STRO) |
US |
$0.367B |
0.00 |
| Nautilus Biotechnology (NAUT) |
US |
$0.366B |
0.00 |
| Inozyme Pharma (INZY) |
US |
$0.361B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
US |
$0.360B |
0.00 |
| Solid Biosciences (SLDB) |
US |
$0.357B |
0.00 |
| Nkarta (NKTX) |
US |
$0.348B |
0.00 |
| Cabaletta Bio (CABA) |
US |
$0.347B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
GB |
$0.343B |
0.00 |
| Kamada (KMDA) |
IL |
$0.341B |
25.83 |
| XOMA Royalty (XOMA) |
US |
$0.340B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
US |
$0.330B |
0.00 |
| Amarin (AMRN) |
IE |
$0.327B |
0.00 |
| MeiraGTx Holdings (MGTX) |
US |
$0.325B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
US |
$0.317B |
0.00 |
| ALX Oncology Holdings (ALXO) |
US |
$0.315B |
0.00 |
| Cartesian Therapeutics (RNAC) |
US |
$0.311B |
0.00 |
| Jasper Therapeutics (JSPR) |
US |
$0.310B |
0.00 |
| Scilex Holding (SCLX) |
US |
$0.305B |
0.00 |
| Tenaya Therapeutics (TNYA) |
US |
$0.305B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.300B |
0.00 |
| Design Therapeutics (DSGN) |
US |
$0.297B |
0.00 |
| Inovio Pharmaceuticals (INO) |
US |
$0.293B |
0.00 |
| Alimera Sciences (ALIM) |
US |
$0.292B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
US |
$0.269B |
0.00 |
| Codexis (CDXS) |
US |
$0.261B |
0.00 |
| Prima BioMed (IMMP) |
AU |
$0.258B |
0.00 |
| Mersana Therapeutics (MRSN) |
US |
$0.257B |
0.00 |
| Gossamer Bio (GOSS) |
US |
$0.253B |
0.00 |
| CorMedix Inc (CRMD) |
US |
$0.250B |
0.00 |
| Zura Bio (ZURA) |
US |
$0.248B |
0.00 |
| 2seventy Bio (TSVT) |
US |
$0.246B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
US |
$0.236B |
0.00 |
| Generation Bio (GBIO) |
US |
$0.234B |
0.00 |
| Molecular Partners AG (MOLN) |
CH |
$0.233B |
0.00 |
| ChromaDex (CDXC) |
US |
$0.232B |
0.00 |
| Trevi Therapeutics (TRVI) |
US |
$0.229B |
0.00 |
| Caribou Biosciences (CRBU) |
US |
$0.225B |
0.00 |
| XBiotech (XBIT) |
US |
$0.221B |
0.00 |
| 23andMe Holding (ME) |
US |
$0.216B |
0.00 |
| Shattuck Labs (STTK) |
US |
$0.210B |
0.00 |
| Acumen Pharmaceuticals (ABOS) |
US |
$0.209B |
0.00 |
| Abeona Therapeutics (ABEO) |
US |
$0.209B |
0.00 |
| Greenwich LifeSciences (GLSI) |
US |
$0.208B |
0.00 |
| Ventyx Biosciences (VTYX) |
US |
$0.208B |
0.00 |
| G1 Therapeutics (GTHX) |
US |
$0.204B |
0.00 |
| Oncobiologics (OTLK) |
US |
$0.200B |
0.00 |
| GENFIT S.A (GNFT) |
FR |
$0.200B |
0.00 |
| Seres Therapeutics (MCRB) |
US |
$0.200B |
0.00 |
| Candel Therapeutics (CADL) |
US |
$0.199B |
0.00 |
| Biomea Fusion (BMEA) |
US |
$0.199B |
0.00 |
| Inhibrx Biosciences (INBX) |
|
$0.199B |
0.00 |
| Coherus BioSciences (CHRS) |
US |
$0.197B |
0.00 |
| Renovaro (RENB) |
US |
$0.193B |
0.00 |
| Lifecore Biomedical (LFCR) |
US |
$0.190B |
0.00 |
| Rezolute (RZLT) |
US |
$0.188B |
0.00 |
| Puma Biotechnology (PBYI) |
US |
$0.185B |
11.61 |
| FibroBiologics (FBLG) |
US |
$0.183B |
0.00 |
| Sangamo Therapeutics (SGMO) |
US |
$0.179B |
0.00 |
| ScPharmaceuticals (SCPH) |
US |
$0.178B |
0.00 |
| Adherex Technologies (FENC) |
US |
$0.178B |
217.00 |
| Adocia (ADOCY) |
FR |
$0.178B |
0.00 |
| Vigil Neuroscience (VIGL) |
US |
$0.174B |
0.00 |
| Skye Bioscience (SKYE) |
US |
$0.173B |
0.00 |
| Innate Pharma S.A (IPHA) |
FR |
$0.172B |
0.00 |
| Kodiak Sciences (KOD) |
US |
$0.171B |
0.00 |
| INmune Bio (INMB) |
US |
$0.170B |
0.00 |
| Adverum Biotechnologies (ADVM) |
US |
$0.170B |
0.00 |
| Repare Therapeutics (RPTX) |
CA |
$0.167B |
0.00 |
| Alpha Teknova (TKNO) |
US |
$0.167B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
US |
$0.166B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
US |
$0.161B |
0.00 |
| Elevation Oncology (ELEV) |
US |
$0.160B |
0.00 |
| Regencell Bioscience Holdings (RGC) |
HK |
$0.160B |
0.00 |
| Invivyd (IVVD) |
US |
$0.158B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
US |
$0.156B |
0.00 |
| ATyr Pharma (ATYR) |
US |
$0.153B |
0.00 |
| ProQR Therapeutics (PRQR) |
NL |
$0.153B |
0.00 |
| Compass Therapeutics (CMPX) |
US |
$0.149B |
0.00 |
| Rani Therapeutics Holdings (RANI) |
US |
$0.148B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
US |
$0.145B |
0.00 |
| PDS Biotechnology (PDSB) |
US |
$0.142B |
0.00 |
| BioStem Technologies (BSEM) |
|
$0.139B |
0.00 |
| Agenus (AGEN) |
US |
$0.138B |
0.00 |
| Seer (SEER) |
US |
$0.134B |
0.00 |
| Bluebird Bio (BLUE) |
US |
$0.133B |
0.00 |
| Opthea (OPT) |
AU |
$0.131B |
0.00 |
| Adicet Bio (ACET) |
US |
$0.131B |
0.00 |
| Immunic (IMUX) |
US |
$0.131B |
0.00 |
| Adlai Nortye (ANL) |
KY |
$0.129B |
0.00 |
| Cellectis S.A (CLLS) |
FR |
$0.128B |
0.00 |
| Nuvectis Pharma (NVCT) |
US |
$0.127B |
0.00 |
| Athira Pharma (ATHA) |
US |
$0.127B |
0.00 |
| Annovis Bio (ANVS) |
US |
$0.122B |
0.00 |
| Akoya Biosciences (AKYA) |
US |
$0.121B |
0.00 |
| Inventiva S.A (IVA) |
FR |
$0.120B |
0.00 |
| Werewolf Therapeutics (HOWL) |
US |
$0.119B |
0.00 |
| CytomX Therapeutics (CTMX) |
US |
$0.117B |
7.50 |
| Rapt Therapeutics (RAPT) |
US |
$0.117B |
0.00 |
| TELA Bio (TELA) |
US |
$0.113B |
0.00 |
| Semper Paratus Acquisition (TVGN) |
US |
$0.113B |
0.00 |
| Adagene (ADAG) |
CN |
$0.111B |
0.00 |
| I-Mab (IMAB) |
CN |
$0.110B |
0.00 |
| Coya Therapeutics (COYA) |
US |
$0.107B |
0.00 |
| Omega Therapeutics (OMGA) |
US |
$0.106B |
0.00 |
| Cardiff Oncology (CRDF) |
US |
$0.105B |
0.00 |
| Sagimet Biosciences (SGMT) |
US |
$0.104B |
0.00 |
| Tiziana Life Sciences (TLSA) |
GB |
$0.102B |
0.00 |
| VistaGen Therapeutics (VTGN) |
US |
$0.100B |
0.00 |
| BioHarvest Sciences (CNVCF) |
CA |
$0.098B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.098B |
0.00 |
| Cognition Therapeutics (CGTX) |
US |
$0.095B |
0.00 |
| HilleVax (HLVX) |
US |
$0.094B |
0.00 |
| Cidara Therapeutics (CDTX) |
US |
$0.093B |
0.00 |
| Eton Pharmaceuticals (ETON) |
US |
$0.092B |
89.50 |
| Elutia (ELUT) |
US |
$0.092B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
US |
$0.092B |
0.00 |
| InflaRx (IFRX) |
DE |
$0.090B |
0.00 |
| DBV Technologies S.A (DBVT) |
FR |
$0.090B |
0.00 |
| Benitec Biopharma (BNTC) |
US |
$0.088B |
0.00 |
| LENZ Therapeutics (LENZ) |
US |
$0.087B |
0.00 |
| Clearside Biomedical (CLSD) |
US |
$0.087B |
0.00 |
| CervoMed Inc. (CRVO) |
US |
$0.087B |
0.00 |
| IO Biotech, Inc. (IOBT) |
DK |
$0.085B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.083B |
0.00 |
| Ikena Oncology, Inc. (IKNA) |
US |
$0.082B |
0.00 |
| Instil Bio, Inc. (TIL) |
US |
$0.081B |
0.00 |
| Allakos Inc. (ALLK) |
US |
$0.081B |
0.00 |
| Milestone Pharmaceuticals Inc. (MIST) |
CA |
$0.080B |
0.00 |
| Estrella Immunopharma, Inc. (ESLA) |
US |
$0.080B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.080B |
0.00 |
| Chimerix, Inc. (CMRX) |
US |
$0.080B |
0.00 |
| Oncolytics Biotech Inc. (ONCY) |
CA |
$0.079B |
0.00 |
| Kronos Bio, Inc. (KRON) |
US |
$0.079B |
0.00 |
| Affimed N.V. (AFMD) |
DE |
$0.078B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.078B |
0.00 |
| Eyenovia, Inc. (EYEN) |
US |
$0.078B |
0.00 |
| Spero Therapeutics, Inc. (SPRO) |
US |
$0.077B |
2.81 |
| BeyondSpring Inc. (BYSI) |
US |
$0.077B |
0.00 |
| Genenta Science S.p.A. Unsponsored ADR (GNTA) |
IT |
$0.076B |
0.00 |
| Genelux Corporation (GNLX) |
US |
$0.075B |
0.00 |
| Ovid Therapeutics (OVID) |
US |
$0.075B |
0.00 |
| Verastem, Inc. (VSTM) |
US |
$0.075B |
0.00 |
| Eledon Pharmaceuticals, Inc. (ELDN) |
US |
$0.073B |
0.00 |
| Eupraxia Pharmaceuticals Inc. (EPRX) |
CA |
$0.071B |
0.00 |
| Gritstone bio Inc. (GRTS) |
US |
$0.071B |
0.00 |
| Precision BioSciences, Inc. (DTIL) |
US |
$0.070B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.069B |
0.00 |
| Galena Biopharma, Inc. (SLS) |
US |
$0.068B |
0.00 |
| Theratechnologies Inc. (THTX) |
CA |
$0.067B |
0.00 |
| Earth Science Tech, Inc. (ETST) |
US |
$0.066B |
0.00 |
| Vor Biopharma Inc. (VOR) |
|
$0.066B |
0.00 |
| Intensity Therapeutics Inc. (INTS) |
US |
$0.064B |
0.00 |
| MediciNova, Inc. (MNOV) |
US |
$0.064B |
0.00 |
| vTv Therapeutics Inc. (VTVT) |
US |
$0.064B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.061B |
0.00 |
| HOOKIPA Pharma Inc. (HOOK) |
US |
$0.061B |
0.00 |
| Entera Bio Ltd. (ENTX) |
IL |
$0.060B |
0.00 |
| Enzo Biochem, Inc. (ENZ) |
US |
$0.059B |
0.00 |
| Immix Biopharma, Inc. (IMMX) |
US |
$0.059B |
0.00 |
| Turnstone Biologics Corp. (TSBX) |
US |
$0.059B |
0.00 |
| Aerovate Therapeutics, Inc. (AVTE) |
US |
$0.058B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.057B |
0.00 |
| Passage Bio, Inc. (PASG) |
US |
$0.057B |
0.00 |
| Rallybio Corporation (RLYB) |
US |
$0.056B |
0.00 |
| Leap Therapeutics, Inc. (LPTX) |
US |
$0.056B |
0.00 |
| Aileron Therapeutics, Inc. (ALRN) |
US |
$0.055B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.055B |
0.00 |
| Prenetics Global Limited (PRE) |
HK |
$0.054B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.053B |
0.00 |
| Lexaria Bioscience Corp. (LEXX) |
CA |
$0.053B |
0.00 |
| Ocuphire Pharma, Inc. (OCUP) |
US |
$0.053B |
0.00 |
| Elicio Therapeutics, Inc. (ELTX) |
US |
$0.050B |
0.00 |
| Lantern Pharma Inc. (LTRN) |
US |
$0.049B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.049B |
0.00 |
| Kezar Life Sciences, Inc. (KZR) |
US |
$0.049B |
0.00 |
| Fortress Biotech, Inc. (FBIO) |
US |
$0.046B |
0.00 |
| NextCure, Inc. (NXTC) |
US |
$0.046B |
0.00 |
| ARCA biopharma, Inc. (ABIO) |
US |
$0.046B |
0.00 |
| Dyadic International Inc. (DYAI) |
US |
$0.045B |
0.00 |
| LakeShore Biopharma Co., Ltd. (LSB) |
CN |
$0.044B |
0.00 |
| Ocean Biomedical, Inc. (OCEA) |
US |
$0.044B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.043B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.042B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.042B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.042B |
0.00 |
| Longeveron Inc. (LGVN) |
US |
$0.042B |
0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA) |
US |
$0.040B |
0.00 |
| OKYO Pharma Limited Sponsored ADR (OKYO) |
|
$0.039B |
0.00 |
| Aadi Bioscience, Inc. (AADI) |
US |
$0.039B |
0.00 |
| Xilio Therapeutics, Inc. (XLO) |
US |
$0.037B |
0.00 |
| IN8bio, Inc. (INAB) |
US |
$0.037B |
0.00 |
| Immuneering Corporation (IMRX) |
US |
$0.037B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.036B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.036B |
0.00 |
| Achilles Therapeutics PLC Sponsored ADR (ACHL) |
GB |
$0.034B |
0.00 |
| Quince Therapeutics, Inc. (QNCX) |
US |
$0.034B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.034B |
0.00 |
| Cyclo Therapeutics, Inc. (CYTH) |
US |
$0.033B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.033B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.032B |
0.00 |
| MiNK Therapeutics, Inc. (INKT) |
US |
$0.031B |
0.00 |
| NKGen Biotech, Inc. (NKGN) |
US |
$0.031B |
0.00 |
| RenovoRx, Inc. (RNXT) |
US |
$0.031B |
0.00 |
| Dare Bioscience, Inc. (DARE) |
US |
$0.031B |
0.00 |
| Pluri Inc. (PLUR) |
IL |
$0.030B |
0.00 |
| Promis Neurosciences (PMN) |
CA |
$0.030B |
0.00 |
| Beyond Air, Inc. (XAIR) |
US |
$0.029B |
0.00 |
| Equillium, Inc. (EQ) |
US |
$0.029B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.029B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.029B |
0.00 |
| Lisata Therapeutics, Inc. (LSTA) |
US |
$0.028B |
0.00 |
| SAB Biotherapeutics, Inc. (SABS) |
US |
$0.026B |
0.00 |
| Femasys Inc. (FEMY) |
US |
$0.025B |
0.00 |
| UNITY Biotechnology, Inc. (UBX) |
US |
$0.025B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.025B |
0.00 |
| Biora Therapeutics, Inc. (BIOR) |
US |
$0.024B |
0.00 |
| NeuroBo Pharmaceuticals, Inc. (NRBO) |
US |
$0.024B |
0.00 |
| HCW Biologics Inc. (HCWB) |
US |
$0.023B |
0.00 |
| Spruce Biosciences, Inc. (SPRB) |
US |
$0.022B |
0.00 |
| Pieris Pharmaceuticals, Inc. (PIRS) |
US |
$0.022B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.022B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.022B |
0.00 |
| Evogene Ltd. (EVGN) |
IL |
$0.021B |
0.00 |
| Carmell Corporation (CTCX) |
US |
$0.021B |
0.00 |
| Cara Therapeutics, Inc. (CARA) |
US |
$0.020B |
0.00 |
| Forte Biosciences, Inc. (FBRX) |
US |
$0.020B |
0.00 |
| Vincerx Pharma, Inc. (VINC) |
US |
$0.020B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.020B |
0.00 |
| CytoMed Therapeutics Limited (GDTC) |
SG |
$0.020B |
0.00 |
| Synlogic, Inc. (SYBX) |
US |
$0.020B |
0.00 |
| KALA BIO, Inc. (KALA) |
US |
$0.019B |
0.00 |
| Orgenesis Inc. (ORGS) |
US |
$0.019B |
0.00 |
| Edesa Biotech, Inc. (EDSA) |
CA |
$0.017B |
0.00 |
| Sensei Biotherapeutics, Inc. (SNSE) |
US |
$0.017B |
0.00 |
| Evaxion Biotech A/S Sponsored ADR (EVAX) |
DK |
$0.016B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.016B |
0.00 |
| VBI Vaccines, Inc. (VBIV) |
US |
$0.016B |
0.00 |
| Galecto, Inc. (GLTO) |
DK |
$0.016B |
0.00 |
| Talis Biomedical Corporation (TLIS) |
US |
$0.015B |
0.00 |
| Lumos Pharma, Inc (LUMO) |
US |
$0.015B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.014B |
0.00 |
| IMMURON (IMRN) |
AU |
$0.014B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.014B |
0.00 |
| Kintara Therapeutics, Inc. (KTRA) |
US |
$0.014B |
0.00 |
| Monopar Therapeutics Inc. (MNPR) |
US |
$0.013B |
0.00 |
| NeuroSense Therapeutics Ltd. (NRSN) |
IL |
$0.011B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.011B |
0.00 |
| Imunon, Inc. (IMNN) |
US |
$0.011B |
0.00 |
| Vaccinex, Inc. (VCNX) |
US |
$0.011B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.011B |
0.00 |
| Aptose Biosciences, Inc. (APTO) |
CA |
$0.010B |
0.00 |
| Senti Biosciences, Inc. (SNTI) |
US |
$0.010B |
0.00 |
| Purple Biotech Ltd. Sponsored ADR (PPBT) |
IL |
$0.010B |
0.00 |
| NuCana PLC Sponsored ADR (NCNA) |
GB |
$0.010B |
0.00 |
| Eterna Therapeutics Inc. (ERNA) |
US |
$0.010B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.010B |
0.00 |
| AEterna Zentaris Inc. (AEZS) |
CA |
$0.010B |
0.00 |
| Silo Pharma, Inc. (SILO) |
US |
$0.009B |
0.00 |
| Organovo Holdings, Inc. (ONVO) |
US |
$0.008B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.008B |
0.00 |
| Elevai Labs, Inc. (ELAB) |
US |
$0.008B |
0.00 |
| Moleculin Biotech, Inc. (MBRX) |
US |
$0.008B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.008B |
0.00 |
| Kineta, Inc. (KA) |
US |
$0.008B |
0.00 |
| Pulmatrix, Inc. (PULM) |
US |
$0.008B |
0.00 |
| TC BioPharm (Holdings) PLC Sponsored ADR (TCBP) |
GB |
$0.008B |
0.00 |
| ANEW Medical, Inc. (WENA) |
US |
$0.008B |
0.00 |
| Prana Biotechnology Ltd (ATHE) |
AU |
$0.008B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.007B |
0.00 |
| Sunshine Biopharma, Inc. (SBFM) |
US |
$0.007B |
0.00 |
| Telesis Bio Inc. (TBIO) |
US |
$0.007B |
0.00 |
| Tenax Therapeutics, Inc. (TENX) |
US |
$0.007B |
0.00 |
| Novogen Limited (KZIA) |
AU |
$0.007B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.006B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.006B |
0.00 |
| GeoVax Labs Inc. (GOVX) |
US |
$0.006B |
0.00 |
| TFF Pharmaceuticals, Inc. (TFFP) |
US |
$0.006B |
0.00 |
| Notable Labs, Ltd. (NTBL) |
US |
$0.006B |
0.00 |
| Bionomics Limited Unsponsored ADR (BNOX) |
AU |
$0.006B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.005B |
0.00 |
| Bright Minds Biosciences Inc. (DRUG) |
US |
$0.005B |
0.00 |
| Pasithea Therapeutics Corp. (KTTA) |
US |
$0.005B |
0.00 |
| Synaptogenix, Inc. (SNPX) |
US |
$0.005B |
0.00 |
| Lixte Biotechnology Holdings, Inc. (LIXT) |
US |
$0.005B |
0.00 |
| Psyence Biomedical Ltd. (PBM) |
US |
$0.005B |
0.00 |
| Titan Pharmaceuticals, Inc. (TTNP) |
US |
$0.005B |
0.00 |
| Windtree Therapeutics, Inc. (WINT) |
US |
$0.005B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.005B |
0.00 |
| Hepion Pharmaceuticals, Inc. (HEPA) |
US |
$0.005B |
0.00 |
| Mustang Bio, Inc. (MBIO) |
US |
$0.005B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.004B |
0.00 |
| Hoth Therapeutics, Inc. (HOTH) |
US |
$0.004B |
0.00 |
| Soligenix Inc. (SNGX) |
US |
$0.004B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.004B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.004B |
0.00 |
| Virios Therapeutics, Inc. (VIRI) |
US |
$0.004B |
0.00 |
| Trevena, Inc. (TRVN) |
US |
$0.004B |
0.00 |
| Exicure, Inc. (XCUR) |
US |
$0.004B |
0.00 |
| Palisade Bio, Inc. (PALI) |
US |
$0.004B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.004B |
0.00 |
| GT Biopharma, Inc. (GTBP) |
US |
$0.004B |
0.00 |
| GENPREX (GNPX) |
US |
$0.004B |
0.00 |
| Onconetix, Inc. (ONCO) |
US |
$0.004B |
0.00 |
| Genetic Technologies Ltd (GENE) |
AU |
$0.004B |
0.00 |
| Enveric Biosciences, Inc. (ENVB) |
US |
$0.004B |
0.00 |
| Tharimmune, Inc. (THAR) |
US |
$0.004B |
0.00 |
| Portage Biotech Inc. (PRTG) |
|
$0.003B |
0.00 |
| Ensysce Biosciences, Inc. (ENSC) |
US |
$0.003B |
0.00 |
| ZyVersa Therapeutics, Inc. (ZVSA) |
US |
$0.003B |
0.00 |
| Invo BioScience Inc. (INVO) |
US |
$0.003B |
0.00 |
| Atrinsic Inc. (PTIX) |
US |
$0.003B |
0.00 |
| Lipella Pharmaceuticals Inc. (LIPO) |
US |
$0.003B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.003B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.003B |
0.00 |
| Virpax Pharmaceuticals, Inc. (VRPX) |
US |
$0.003B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.003B |
0.00 |
| Sonnet BioTherapeutics Holdings, Inc. (SONN) |
US |
$0.003B |
0.00 |
| Revelation Biosciences, Inc. (REVB) |
US |
$0.003B |
0.00 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) |
US |
$0.002B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.002B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.002B |
0.00 |
| Virax Biolabs Group Limited (VRAX) |
GB |
$0.002B |
0.00 |
| Entero Therapeutics, Inc. (ENTO) |
US |
$0.002B |
0.00 |
| Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) |
IL |
$0.002B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.002B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.002B |
0.00 |
| NeuBase Therapeutics, Inc. (NBSE) |
US |
$0.001B |
0.00 |
| Dermata Therapeutics, Inc. (DRMA) |
US |
$0.001B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.001B |
0.00 |
| Seelos Therapeutics, Inc. (SEEL) |
US |
$0.001B |
0.00 |
| GRI Bio, Inc. (GRI) |
US |
$0.001B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| Alvotech (ALVO) |
|
$0.000B |
0.00 |
| Compugen Ltd. (CGEN) |
IL |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
| LAVA Therapeutics N.V. (LVTX) |
NL |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
GB |
$0.000B |
0.00 |
| Mainz Biomed NV (MYNZ) |
DE |
$0.000B |
0.00 |
| PDL BioPharma, Inc. (PDLI) |
US |
$0.000B |
0.00 |
| Pharvaris N.V. (PHVS) |
NL |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
CH |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
